BioCentury
ARTICLE | Clinical News

Acurox regulatory update

July 6, 2009 7:00 AM UTC

Acura and King said FDA issued a complete response letter for an NDA for Acurox oxycodone/niacin tablets to treat moderate to severe pain. The companies said FDA raised issues about the potential abus...